Public Alert No:31/2021 – Johnson & Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA® and AVEENO® Aerosol Sunscreen Products Due to the Presence of Benzene
, The National Agency for Food and Drug Administration and Control has been informed by US FDA that Johnson & Johnson Consumer Inc. (JJCI) is voluntarily recalling all lots of five NEUTROGENA® and AVEENO® aerosol sunscreen product lines to the consumer level. The recall was due to low levels of benzene identified in some samples […]
Public Alert No. 030/2021 – Alert on Recall of All Unexpired Lots of Alpha Male Plus Male Enhancer fruit chews by Alpha Male Plus Due to the Presence of Undeclared Tadalafil and Sildenafil
, The National Agency for Food and Drug Administration and Control has been informed by the U.S. Food and Drug Administration that Tucson, AZ, Alpha Male Plus is voluntarily recalling all lots of unexpired Alpha Male Plus Male Enhancer fruit chews. The result of analysis by FDA found the product to contain undeclared tadalafil, an […]
Public Alert No: 29/2021 – Prairie Wolf Spirits Inc. Recalls Prairie Wolf Distillery Hand Sanitizer Packed In 16.9 Oz And 20.0 Oz Bottles Resembling Drinking Water Containers
, The National Agency for Food and Drug Administration and Control (NAFDAC) has received information from US FDA on the voluntary recall by manufacturer of Prairie Wolf Distillery hand sanitizer packaged in 16.9 fluid ounce (UPC 6000331899) and 20.0 fluid ounce (UPC 6000365984) containers to the consumer level. The product poses a risk of ingestion […]
Public Alert No. 28/2021 – Alert on Recall of Chantix (Varenicline) Tablets by Pfizer, Due to the Presence of Nitrosamine, N-Nitroso-Varenicline above Pfizer Established Acceptable Daily Intake (ADI) Level.
, The National Agency for Food and Drug Administration and Control (NAFDAC) has received information from US FDA that Pfizer is voluntarily recalling twelve (12) lots of Chantix (Verencline) Tablets – two 0.5 mg tablet lots, two 1.0 mg tablet lots, and eight lots of a Chantix kit that includes both 0.5 mg and 1.0 […]
Public Alert No.027/2021- Statins: Drug Safety Communication – US Food And Drug Administration (FDA) Requests Removal Of Strongest Warning Against Using Cholesterol-Lowering Statins During Pregnancy
, The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed by the U.S FDA about revisions to the prescribing information of the entire class of statin medicines, regarding their use in pregnancy. These changes include removing the contraindication against using these medicines in all pregnant patients. A contraindication is FDA’s […]
DG’s Flag-off of the Agency’s Sensitization Campaigns
, ADDRESS BY DIRECTOR-GENERAL OF NAFDAC, PROF. MOJI CHRISTIANAH ADEYEYE AT THE FLAG-OFF OF THE AGENCY’S SENSITIZATION CAMPAIGNS ON WEDNESDAY 4TH AUGUST,2021 IN ABUJA. PROTOCOLS It is indeed a great pleasure for me to welcome you all to this very important and significant sensitization campaign scheduled to hold in Eight States of the Federation. The […]
Public Alert No. 026/2021 – Alert On Recall Of Imperia Elita Vitaccino Coffee By Dash Xclusive Due To The Presence Of Undeclared Sibutramine And Fluoxetine
, The National Agency for Food and Drug Administration and Control (NAFDAC) has received information from US FDA that Dash Xclusive is voluntarily recalling all lots of Imperia Elita Vitaccino Coffee. This was due to FDA’s result of analysis which has shown the product contains undeclared sibutramine and fluoxetine. Sibutramine was an FDA-approved drug used […]
Public Alert No. 025/2021- Alert on Recall of Poseidon Platinum 3500 by Yamtun7 Due to the Presence of Undeclared Tadalafil and Sildenafil
, The National Agency for Food and Drug Administration and Control has been informed by the U.S. Food and Drug Administration that Yamtun7 is voluntarily recalling all lots of Poseidon Platinum 3500. The result of analysis by FDA found the product to contain undeclared tadalafil and sildenafil. Tadalafil and sildenafil are drugs known as phosphodiesterase […]
NAFDAC Recommends The Following Vaccines For Emergency Use Authorization
, Moderna (Rovi Pharma Madrid, Spain) AstraZeneca AZD1222 Sputnik V (Gamaleya National Centre of Epidemiology and Microbiology, Russia) INTRODUCTION NAFDAC is announcing the approval of Moderna and AstraZeneca vaccines and conditional approval of Sputnik V vaccine. The NAFDAC Vaccine Committee has been carefully assessing several vaccines despite the fact the vaccines have been approved by […]
Public Alert No.024/2021 – Boston Scientific Corporation Recalls VICI VENOUS STENT System and VICI RDS VENOUS STENT System for Potential of Stent Migration
, The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed by the U.S Food and Drug Administration (FDA) that Boston Scientific is recalling the VICI VENOUS STENT System (VICI SDS) and RDS VENOUS STENT Systems after reports indicate that the stents may migrate or move from where they are initially […]
